Abstract
The most obvious function of the sebaceous gland is to excrete sebum [1, 2]. For a long time hyperseborrhea has been considered as a major etiopathogenetic factor for the development of acne. However, current research provides evidence that sebum quantity per se cannot be the only responsible factor, as demonstrated by the success of treatment with agents with no primary effect on sebum excretion rate [3]. Indeed, additional functions of the gland are associated with the development of acne (Table 23.1), with prominent among them alterations in sebaceous lipid fractions.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
FormalPara Core Messages-
Currently reported data strongly indicate a central role of sebaceous lipid quality and not quantity on the development of acne and other inflammatory skin diseases.
-
Several lipid fractions, especially sebaceous lipid fractions, also express antibacterial activity, possibly protecting the sebaceous gland from major infections.
1 Introduction
The most obvious function of the sebaceous gland is to excrete sebum [1, 2]. For a long time hyperseborrhea has been considered as a major etiopathogenetic factor for the development of acne. However, current research provides evidence that sebum quantity per se cannot be the only responsible factor, as demonstrated by the success of treatment with agents with no primary effect on sebum excretion rate [3]. Indeed, additional functions of the gland are associated with the development of acne (Table 23.1), with prominent among them alterations in sebaceous lipid fractions.
2 Sebaceous Glands and Innate Immunity
Keratinocytes and sebocytes, as major components of the pilosebaceous unit, may act as immune-active cells capable of microbial recognition and abnormal lipid presentation (see Chap. 16). Acting that way, keratinocytes and sebocytes may be activated by P. acnes and recognize altered lipid content in sebum, followed by the production of proinflammatory cytokines. In addition, antimicrobial peptides, such as defensin-1, defensin-2, and cathelicidin, are expressed and are immune reactive in the sebaceous gland [16–19]. Human β-defensin-2 (hBD-2) is expressed upon exposure to lipopolysaccharides and P. acnes [18] and upregulated by sebum free fatty acids [19]. Stearoyl coenzyme A desaturase (SCD), an enzyme responsible for the biosynthesis of monounsaturated fatty acids, is also expressed by the sebaceous gland [20, 21]. The TLR-2 ligand macrophage-activating lipopeptide-2 stimulates both SCD and its downstream enzyme fatty acid desaturase-2 in SZ95 sebocytes.
3 Sebum
Sebum is the first demonstrable glandular product of the human body [22]. It is a mixture of relatively nonpolar lipids [22, 23], most of which are synthesized de novo by the sebaceous gland of the mammals to coat the fur as a hydrophobic protection against overwetting and for heat insulation [22, 24]. The composition of sebum is remarkably species specific [4, 22, 25].
4 Sebaceous Lipids
Human sebaceous glands secrete a lipid mixture containing squalene and wax esters, as well as cholesterol esters, triglycerides, and possibly some free cholesterol [22, 23, 26–28]. Bacterial hydrolases convert some of the triglycerides to free fatty acids on the skin surface [29, 30], however, there is also evidence indicating that sebaceous glands can also synthesize considerable amounts of free fatty acids [15].
5 Alterations in Acne
It is not long ago that the oxidant/antioxidant ratio of the skin surface lipids [31] and currently alterations of fatty acid composition [32, 33] have been taken into consideration in the etiopathogenesis of acne and other skin diseases (Fig. 23.1). Lower essential fatty acid levels were found in wax esters in twins with acne rather than in twins without acne [34]. The sebaceous ω9-fatty acids sapienate C16:1δ6, palmitate C16:0, and oleate (C18:1) are very effective against Staphylococcus aureus [12, 16, 20, 35]. Lipids at the skin surface, mostly secreted from the sebaceous glands (90 %) and transported through the follicular canal, are part of the innate immunity of the skin and contribute to the antimicrobial skin barrier. On the other hand, dysfunction of the upstream lipidogenic enzymes stearoyl-CoA desaturase and fatty acid desaturase 2 is associated with skin infection and inflammation [20, 21]. However, neither all ω6-fatty acids are comedogenic nor all ω9-fatty acids (Fig. 23.2) inhibit comedogenesis. For example, oleate alters the calcium dynamics in epidermal keratinocytes and induces abnormal follicular keratinization leading to comedogenesis in rabbit skin but to minor irritation in human skin [36]. Overall, free fatty acids were detected to express proinflammatory and anti-inflammatory properties [13, 19, 37, 38].
Altered ratio between saturated and unsaturated fatty acids has been indicated as an important feature to be considered in addition to the altered amount of specific fatty acids such as linoleate (LA; C18:2), an essential ω6-fatty acid that cannot be synthesized in vivo, and therefore must be obtained from the diet [33]. High levels of sebum LA may protect from the development of comedonal acne [39]. On the other hand, low LA levels have been observed in skin surface lipids of acne patients [40]. Its topical application reduces microcomedones and inhibits steroid 5α-reductase activity [41, 42].
Particular attention has been focused on peroxidation of squalene, another sebaceous gland-specific lipid, e.g., by UV radiation, which led to comedogenesis on the rabbit ear skin [43]. Moreover, squalene peroxide seems able to induce an inflammatory response beyond cytotoxicity and comedone formation [33]. Oxygen and microorganisms transform “native” sebum with lysis of triglycerides to fatty acids being the most pronounced activity [7, 44]. Certain components of this complex mixture of molecules present in the sebum are clearly cytotoxic or irritant, provoking reactive follicular hyperkeratosis and comedone formation—the first step to acne. As discussed above, IL-1α levels are a hallmark of comedogenesis [45, 46] and, while P. acnes is unable to induce IL-1α expression in the pilosebaceous unit [47, 48], oleate—through keratinocyte toxicity—causes increased IL-1α mRNA levels. The quantities of lipid peroxide, IL-1α, and NF-κB were found significantly higher in the content of comedones than those in the stratum corneum, indicating that the accumulation of a certain amount of lipid peroxide in the content of comedones may play an important role in the progression of comedogenesis [25] and the inflammatory changes detected in these apparently non-inflammatory lesions [2, 15]. In any case, scarce inflammatory infiltrates around the ductus seboglandularis and later on perifollicular infiltration are closely associated with comedone formation [2, 15, 49] and does not develop in a later stage leading to “inflammatory comedones,” as previously reported [43].
Conclusions
Increased sebum excretion, alteration of lipid composition and the oxidant/antioxidant ratio of the skin surface lipids are major concurrent events associated with the development of acne [1]. Interestingly, currently reported data strongly indicate a central role of sebaceous lipid quality and not quantity on the development of acne and other inflammatory skin diseases. Moreover, several lipid fractions, especially sebaceous lipid fractions, also express antibacterial activity, possibly protecting the sebaceous gland from major infections.
References
Zouboulis CC. Acne and sebaceous gland function. Clin Dermatol. 2004;22:360–6.
Zouboulis CC, Eady A, Philpott M, et al. What is the pathogenesis of acne? Exp Dermatol. 2005;14:143–52.
Kurokawa I, Danby FW, Ju Q, et al. New developments in our understanding of acne pathogenesis and treatment. Exp Dermatol. 2009;18:821–32.
Zouboulis CC, Fimmel S, Ortmann J, et al. Sebaceous glands. In: Hoath SB, Maibach HI, editors. Neonatal skin: structure and function. 2nd ed. New York: Dekker; 2003. p. 59–88.
Chen W, Tsai S-J, Sheu H-M, Tsai J-C, Zouboulis CC. Testosterone synthesized in cultured human SZ95 sebocytes mainly derives from dehydroepiandrosterone. Exp Dermatol. 2010;19:470–2.
Fritsch M, Orfanos CE, Zouboulis CC. Sebocytes are the key regulators of androgen homeostasis in human skin. J Invest Dermatol. 2001;116:793–800.
Saint-Léger D. Fonction sébacée normale et pathologique. Des recherches au milieu du gué ? Pathol Biol (Paris). 2003;51:275–8.
Thiboutot D, Jabara S, McAllister JM, et al. Human skin is a steroidogenic tissue: steroidogenic enzymes and cofactors are expressed in epidermis, normal sebocytes, and an immortalized sebocyte cell line (SEB-1). J Invest Dermatol. 2003;120:905–14.
Zouboulis CC. The human skin as a hormone target and an endocrine gland. Hormones. 2004;3:9–26.
Zouboulis CC. Acne vulgaris and rosacea. In: Granstein RD, Luger T, editors. Neuroimmunology of the skin – basic science to clinical practice. Berlin: Springer; 2009. p. 219–32.
Zouboulis CC, Seltmann H, Hiroi N, et al. Corticotropin releasing hormone: an autocrine hormone that promotes lipogenesis in human sebocytes. Proc Natl Acad Sci USA. 2002;99:7148–53.
Wille JJ, Kydonieus A. Palmitoleic acid isomer (C16:1δ6) is the active antimicrobial fatty acid in human skin sebum. Skin Pharmacol Appl Skin Physiol. 2003;16:176–87.
Alestas T, Ganceviciene R, Fimmel S, Müller-Decker K, Zouboulis CC. Enzymes involved in the biosynthesis of leukotriene B4 and prostaglandin E2 are active in sebaceous glands. J Mol Med. 2006;84:75–87.
Böhm M, Schiller M, Ständer S, et al. Evidence for expression of melanocortin-1 receptor in human sebocytes in vitro and in situ. J Invest Dermatol. 2002;118:533–9.
Zouboulis CC. Is acne vulgaris a genuine inflammatory disease? Dermatology. 2001;203:277–9.
Chen CH, Wang Y, Nakatsuji T, et al. An innate bactericidal oleic acid effective against skin infection of methicillin-resistant staphylococcus aureus: a therapy concordant with evolutionary medicine. J Microbiol Biotechnol. 2011;21:391–9.
Chronnell CM, Ghali LR, Ali RS, et al. Human beta defensin-1 and -2 expression in human pilosebaceous units: upregulation in acne vulgaris lesions. J Invest Dermatol. 2001;117:1120–5.
Nagy I, Pivarcsi A, Kis K, et al. Propionibacterium acnes and lipopolysaccharide induce the expression of antimicrobial peptides and proinflammatory cytokines/chemokines in human sebocytes. Microbes Infect. 2006;8:2195–205.
Nakatsuji T, Kao MC, Zhang L, Zouboulis CC, Gallo RL, Huang C-M. Sebum free fatty acids enhance the innate immune defense of human sebocytes by upregulating β-defensin-2 expression. J Invest Dermatol. 2010;130:985–94.
Georgel P, Crozat K, Lauth X, et al. A toll-like receptor 2-responsive lipid effector pathway protects mammals against skin infections with Gram-positive bacteria. Infect Immun. 2005;73:4512–21.
Zouboulis CC, Angres S, Seltmann H. Regulation of stearoyl-CoA desaturase and fatty acid desaturase 2 expression by linoleic acid and arachidonic acid in human sebocytes leads to enhancement of proinflammatory activity but does not affect lipogenesis. Br J Dermatol. 2011;165:269–76.
Nikkari T. Comparative chemistry of sebum. J Invest Dermatol. 1974;62:257–67.
Picardo M, Ottaviani M, Camera E, Mastrofrancesco A. Sebaceous gland lipids. Dermatoendocrinology. 2009;1:68–71.
Pochi P. The sebaceous gland. In: Maibach HI, Boisits EK, editors. Neonatal skin: structure and function. New York: Dekker; 1982. p. 67–80.
Tochio T, Tanaka H, Nakata S, Ikeno H. Accumulation of lipid peroxide in the content of comedones may be involved in the progression of comedogenesis and inflammatory changes in comedones. J Cosmet Dermatol. 2009;8:152–8.
Camera E, Ludovici M, Galante M, Sinagra J-L, Picardo M. Comprehensive analysis of the major lipid classes in sebum by rapid resolution high-performance liquid chromatography and electrospray mass spectrometry. J Lipid Res. 2010;51:3377–88.
Ramasastry P, Downing DT, Pochi PE, et al. Chemical composition of human skin surface lipids from birth to puberty. J Invest Dermatol. 1970;54:139–44.
Thody AJ, Shuster S. Control and function of sebaceous glands. Physiol Rev. 1989;69:383–416.
Nicolaides N, Wells GC. On the biogenesis of the free fatty acids in human skin surface fat. J Invest Dermatol. 1957;29:423–33.
Shalita AR. Genesis of free fatty acids. J Invest Dermatol. 1974;62:332–5.
Stewart ME, Grahek MO, Cambier LS, Wertz PW, Downing DT. Dilutional effect of increased sebaceous gland activity on the proportion of linoleic acid in sebaceous wax esters and in epidermal acylceramides. J Invest Dermatol. 1986;87:733–6.
Makrantonaki E, Ganceviciene R, Zouboulis CC. An update on the role of the sebaceous gland in the pathogenesis of acne. Dermatoendocrinology. 2011;3:41–9.
Ottaviani M, Camera E, Picardo M. Lipid mediators in acne. Mediators Inflamm 2010;pii 858176.
Stewart ME. Sebaceous gland lipids. Semin Dermatol. 1992;11:100–5.
Drake DR, Brogden KA, Dawson DV, Wertz PW. Antimicrobial lipids at the skin surface. J Lipid Res. 2008;49:4–11.
Boelsma E, Tanojo H, Boddé HE, Ponec M. Assessment of the potential irritancy of oleic acid on human skin: evaluation in vitro and in vivo. Toxicol In Vitro. 1996;10:729–42.
Makrantonaki E, Zouboulis CC. Testosterone metabolism to 5α-dihydrotestosterone and synthesis of sebaceous lipids is regulated by the peroxisome proliferators-activated receptor ligand linoleic acid in human sebocytes. Br J Dermatol. 2007;156:428–32.
Wróbel A, Seltmann H, Fimmel S, et al. Differentiation and apoptosis in human immortalized sebocytes. J Invest Dermatol. 2003;120:175–81.
Nicolaides N, Fu HC, Ansari MNA, et al. The fatty acids of esters and sterol esters from vernix caseosa and from human surface lipid. Lipids. 1972;7:506–17.
Downing DT, Stewart ME, Wertz PW, et al. Essential fatty acids and acne. J Am Acad Dermatol. 1986;14:221–5.
Letawe C, Boone M, Piérard GE. Digital image analysis of the effect of topically applied linoleic acid on acne microcomedones. Clin Exp Dermatol. 1998;23:56–8.
Namazi MR. Further insight into the pathomechanism of acne by considering the 5-alpha-reductase inhibitory effect of linoleic acid. Int J Dermatol. 2004;43:701.
Chiba K, Yoshizawa K, Makino I, Kawakami K, Onoue M. Comedogenicity of squalene monohydroperoxide in the skin after topical application. J Toxicol Sci. 2000;25:77–83.
Patel SD, Noble WC. Changes in skin surface lipid composition during therapy for severe acne vulgaris and relation to colonisation with propionibacteria. Microb Ecol Health Dis. 1992;5:291–7.
Antilla HS, Reitamo S, Saurat J-H. Interleukin 1 immunoreactivity in sebaceous glands. Br J Dermatol. 1992;127:585–8.
Ingham E, Eady EA, Goodwin CE, Cove JH, Cunliffe WJ. Pro-inflammatory levels of interleukin-1 alpha-like bioactivity are present in the majority of open comedones in acne vulgaris. J Invest Dermatol. 1992;98:895–901.
Ingham E, Walters CE, Eady EA, Cove JH, Kearney JN, Cunliffe WJ. Inflammation in acne vulgaris: failure of skin micro-organisms to modulate keratinocyte interleukin 1 alpha production in vitro. Dermatology. 1998;196:86–8.
Seltmann H, Rudawski IM, Holland KT, Orfanos CE, Zouboulis CC. Propionibacterium acnes does not influence the interleukin-1/interleukin-8 cascade in immortalized human sebocytes in vitro. J Invest Dermatol. 2000;114:816.
Jeremy AH, Holland DB, Roberts SG, Thomson KF, Cunliffe WJ. Inflammatory events are involved in acne lesion initiation. J Invest Dermatol. 2003;121:20–7.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Zouboulis, C.C. (2014). Acne and Antimicrobial Lipids. In: Zouboulis, C., Katsambas, A., Kligman, A. (eds) Pathogenesis and Treatment of Acne and Rosacea. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-69375-8_23
Download citation
DOI: https://doi.org/10.1007/978-3-540-69375-8_23
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-69374-1
Online ISBN: 978-3-540-69375-8
eBook Packages: MedicineMedicine (R0)